Dr. Eleanor Fish (a prominent immunologist at the University of Toronto, Canada) comments that she does not think BCG may completely eliminate infection caused by a novel coronavirus, but it is likely to mitigate the effects of a novel coronavirus on individuals.The scientists involved in the study hope that BCG vaccination may ease the burden on the health system before a specific vaccine for Covid-19 is available.

1.BCG Clinical Trials for Against Covid-19

Researchers in four countries (the Netherlands, Australia, Germany, and the United Kingdom) will soon begin clinical trials of new coronaviruses using unconventional methods.They will test whether a century-old anti-tuberculosis (TB) vaccine (BCG) can broadly improve the body's immune system, making it better able to fight sars-cov-2 and possibly prevent infection altogether.The study will be administered to people at high risk, including physicians and nurses, and to older adults.

A team at the university of Melbourne in Australia is using exactly the same protocol to carry out the BCG study among healthcare workers.Another team at the university of Exeter in the UK will conduct a similar study on older people.Last week, a team at the Max Planck Institute for Infection Biology in Germany announced that, inspired by Netea's work, they would carry out similar clinical trials in older people and healthcare workers with another anti-tb vaccine in development, VPM1002, a genetically modified BCG vaccine."The elderly and health care workers are bearing the brunt of the current outbreak, so they would particularly benefit if the VPM1002 vaccine could help."They said.

2.Introduction of BCG

The BCG vaccine consists of an attenuated (weakened) version of a relative of Mycobacterium tuberculosis, the causative agent of TB. The vaccine is in most countries in the world of children after the birth of the first annual vaccination is used, the BCG vaccine to be both safe and cheap, it can prevent an average of about 60% of TB cases, children vary widely between countries.Vaccines typically produce an immune response against the target pathogen, such as antibodies that bind and neutralize one virus but do not bind to others.But BCG may also enhance the immune system's ability to fight pathogens other than tuberculosis, according to decades of published clinical and observational studies.The researchers concluded that in the first year after vaccination, about 30 percent of all known pathogens, including viruses, could be prevented.A 2014 review by the world health organization concluded that BCG appeared to reduce overall child mortality.

3.BCG can "Train" Innate Immunity

The innate immune system, composed of white blood cells such as macrophages, natural killer cells and neutrophils, should not have this memory.The team, led by professor Netea, found that BCG could survive for months in human skin, stimulating not only the t-cells and b-cells of mycobacterium memoriae, but also the white blood cells responsible for innate immunity, which can quickly respond to new infections.In a randomized placebo-controlled study published in 2018, the team showed that BCG vaccination prevented the yellow fever virus from being experimentally infected.

The global BCG Vaccine for Prevent Covid-19 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for BCG Vaccine for Prevent Covid-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine for Prevent Covid-19.

Report Scope

The BCG Vaccine for Prevent Covid-19 market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG Vaccine for Prevent Covid-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the BCG Vaccine for Prevent Covid-19 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of BCG Vaccine for Prevent Covid-19 Market Report

Report Metric	Details
Report Name	BCG Vaccine for Prevent Covid-19 Market
CAGR	5%
Segment by Type	by Dosage 0.5ml Package 1ml Package 2ml Package Other
by Type of Inoculator	Initial Vaccinate Revaccination
Segment by Application	0-5 Years Old 5-18 Years Old 18-45 Years Old 45-65 Years Old ≥65 Years Old
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, InterVax, Serum Institute of India, GreenSignal, Statens Serum Institute, Shanyao Group, Shanghai Institute of Biological Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG Vaccine for Prevent Covid-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG Vaccine for Prevent Covid-19 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the BCG Vaccine for Prevent Covid-19 Market report?

Ans: The main players in the BCG Vaccine for Prevent Covid-19 Market are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, InterVax, Serum Institute of India, GreenSignal, Statens Serum Institute, Shanyao Group, Shanghai Institute of Biological Products

What are the Application segmentation covered in the BCG Vaccine for Prevent Covid-19 Market report?

Ans: The Applications covered in the BCG Vaccine for Prevent Covid-19 Market report are 0-5 Years Old, 5-18 Years Old, 18-45 Years Old, 45-65 Years Old, ≥65 Years Old

What are the Type segmentation covered in the BCG Vaccine for Prevent Covid-19 Market report?

Ans: The Types covered in the BCG Vaccine for Prevent Covid-19 Market report are Initial Vaccinate, Revaccination

1 BCG Vaccine for Prevent Covid-19 Market Overview

1.1 Product Overview and Scope of BCG Vaccine for Prevent Covid-19

1.2 BCG Vaccine for Prevent Covid-19 Segment by Dosage

1.2.1 Global BCG Vaccine for Prevent Covid-19 Market Value Comparison by Dosage (2024-2030)

1.2.2 0.5ml Package

1.2.3 1ml Package

1.2.4 2ml Package

1.2.5 Other

1.3 BCG Vaccine for Prevent Covid-19 Segment by Application

1.3.1 Global BCG Vaccine for Prevent Covid-19 Market Value by Application: (2024-2030)

1.3.2 0-5 Years Old

1.3.3 5-18 Years Old

1.3.4 18-45 Years Old

1.3.5 45-65 Years Old

1.3.6 ≥65 Years Old

1.4 Global BCG Vaccine for Prevent Covid-19 Market Size Estimates and Forecasts

1.4.1 Global BCG Vaccine for Prevent Covid-19 Revenue 2019-2030

1.4.2 Global BCG Vaccine for Prevent Covid-19 Sales 2019-2030

1.4.3 Global BCG Vaccine for Prevent Covid-19 Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 BCG Vaccine for Prevent Covid-19 Market Competition by Manufacturers

2.1 Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Manufacturers (2019-2024)

2.2 Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Manufacturers (2019-2024)

2.3 Global BCG Vaccine for Prevent Covid-19 Average Price by Manufacturers (2019-2024)

2.4 Global BCG Vaccine for Prevent Covid-19 Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of BCG Vaccine for Prevent Covid-19, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of BCG Vaccine for Prevent Covid-19, Product Type & Application

2.7 BCG Vaccine for Prevent Covid-19 Market Competitive Situation and Trends

2.7.1 BCG Vaccine for Prevent Covid-19 Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest BCG Vaccine for Prevent Covid-19 Players Market Share by Revenue

2.7.3 Global BCG Vaccine for Prevent Covid-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 BCG Vaccine for Prevent Covid-19 Retrospective Market Scenario by Region

3.1 Global BCG Vaccine for Prevent Covid-19 Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global BCG Vaccine for Prevent Covid-19 Global BCG Vaccine for Prevent Covid-19 Sales by Region: 2019-2030

3.2.1 Global BCG Vaccine for Prevent Covid-19 Sales by Region: 2019-2024

3.2.2 Global BCG Vaccine for Prevent Covid-19 Sales by Region: 2025-2030

3.3 Global BCG Vaccine for Prevent Covid-19 Global BCG Vaccine for Prevent Covid-19 Revenue by Region: 2019-2030

3.3.1 Global BCG Vaccine for Prevent Covid-19 Revenue by Region: 2019-2024

3.3.2 Global BCG Vaccine for Prevent Covid-19 Revenue by Region: 2025-2030

3.4 North America BCG Vaccine for Prevent Covid-19 Market Facts & Figures by Country

3.4.1 North America BCG Vaccine for Prevent Covid-19 Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2030)

3.4.3 North America BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe BCG Vaccine for Prevent Covid-19 Market Facts & Figures by Country

3.5.1 Europe BCG Vaccine for Prevent Covid-19 Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2030)

3.5.3 Europe BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific BCG Vaccine for Prevent Covid-19 Market Facts & Figures by Country

3.6.1 Asia Pacific BCG Vaccine for Prevent Covid-19 Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2030)

3.6.3 Asia Pacific BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America BCG Vaccine for Prevent Covid-19 Market Facts & Figures by Country

3.7.1 Latin America BCG Vaccine for Prevent Covid-19 Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2030)

3.7.3 Latin America BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa BCG Vaccine for Prevent Covid-19 Market Facts & Figures by Country

3.8.1 Middle East and Africa BCG Vaccine for Prevent Covid-19 Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2030)

3.8.3 Middle East and Africa BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2030)

4.1.1 Global BCG Vaccine for Prevent Covid-19 Sales by Type (2019-2024)

4.1.2 Global BCG Vaccine for Prevent Covid-19 Sales by Type (2025-2030)

4.1.3 Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2030)

4.2 Global BCG Vaccine for Prevent Covid-19 Revenue by Type (2019-2030)

4.2.1 Global BCG Vaccine for Prevent Covid-19 Revenue by Type (2019-2024)

4.2.2 Global BCG Vaccine for Prevent Covid-19 Revenue by Type (2025-2030)

4.2.3 Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Type (2019-2030)

4.3 Global BCG Vaccine for Prevent Covid-19 Price by Type (2019-2030)

5 Segment by Application

5.1 Global BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2030)

5.1.1 Global BCG Vaccine for Prevent Covid-19 Sales by Application (2019-2024)

5.1.2 Global BCG Vaccine for Prevent Covid-19 Sales by Application (2025-2030)

5.1.3 Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2030)

5.2 Global BCG Vaccine for Prevent Covid-19 Revenue by Application (2019-2030)

5.2.1 Global BCG Vaccine for Prevent Covid-19 Revenue by Application (2019-2024)

5.2.2 Global BCG Vaccine for Prevent Covid-19 Revenue by Application (2025-2030)

5.2.3 Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Application (2019-2030)

5.3 Global BCG Vaccine for Prevent Covid-19 Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck BCG Vaccine for Prevent Covid-19 Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Sanofi Pasteur

6.2.1 Sanofi Pasteur Corporation Information

6.2.2 Sanofi Pasteur Description and Business Overview

6.2.3 Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Product Portfolio

6.2.5 Sanofi Pasteur Recent Developments/Updates

6.3 Japan BCG Lab

6.3.1 Japan BCG Lab Corporation Information

6.3.2 Japan BCG Lab Description and Business Overview

6.3.3 Japan BCG Lab BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Japan BCG Lab BCG Vaccine for Prevent Covid-19 Product Portfolio

6.3.5 Japan BCG Lab Recent Developments/Updates

6.4 China National Biotec

6.4.1 China National Biotec Corporation Information

6.4.2 China National Biotec Description and Business Overview

6.4.3 China National Biotec BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.4.4 China National Biotec BCG Vaccine for Prevent Covid-19 Product Portfolio

6.4.5 China National Biotec Recent Developments/Updates

6.5 InterVax

6.5.1 InterVax Corporation Information

6.5.2 InterVax Description and Business Overview

6.5.3 InterVax BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.5.4 InterVax BCG Vaccine for Prevent Covid-19 Product Portfolio

6.5.5 InterVax Recent Developments/Updates

6.6 Serum Institute of India

6.6.1 Serum Institute of India Corporation Information

6.6.2 Serum Institute of India Description and Business Overview

6.6.3 Serum Institute of India BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Serum Institute of India BCG Vaccine for Prevent Covid-19 Product Portfolio

6.6.5 Serum Institute of India Recent Developments/Updates

6.7 GreenSignal

6.6.1 GreenSignal Corporation Information

6.6.2 GreenSignal Description and Business Overview

6.6.3 GreenSignal BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GreenSignal BCG Vaccine for Prevent Covid-19 Product Portfolio

6.7.5 GreenSignal Recent Developments/Updates

6.8 Statens Serum Institute

6.8.1 Statens Serum Institute Corporation Information

6.8.2 Statens Serum Institute Description and Business Overview

6.8.3 Statens Serum Institute BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Statens Serum Institute BCG Vaccine for Prevent Covid-19 Product Portfolio

6.8.5 Statens Serum Institute Recent Developments/Updates

6.9 Shanyao Group

6.9.1 Shanyao Group Corporation Information

6.9.2 Shanyao Group Description and Business Overview

6.9.3 Shanyao Group BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Shanyao Group BCG Vaccine for Prevent Covid-19 Product Portfolio

6.9.5 Shanyao Group Recent Developments/Updates

6.10 Shanghai Institute of Biological Products

6.10.1 Shanghai Institute of Biological Products Corporation Information

6.10.2 Shanghai Institute of Biological Products Description and Business Overview

6.10.3 Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Product Portfolio

6.10.5 Shanghai Institute of Biological Products Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 BCG Vaccine for Prevent Covid-19 Industry Chain Analysis

7.2 BCG Vaccine for Prevent Covid-19 Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 BCG Vaccine for Prevent Covid-19 Production Mode & Process

7.4 BCG Vaccine for Prevent Covid-19 Sales and Marketing

7.4.1 BCG Vaccine for Prevent Covid-19 Sales Channels

7.4.2 BCG Vaccine for Prevent Covid-19 Distributors

7.5 BCG Vaccine for Prevent Covid-19 Customers

8 BCG Vaccine for Prevent Covid-19 Market Dynamics

8.1 BCG Vaccine for Prevent Covid-19 Industry Trends

8.2 BCG Vaccine for Prevent Covid-19 Market Drivers

8.3 BCG Vaccine for Prevent Covid-19 Market Challenges

8.4 BCG Vaccine for Prevent Covid-19 Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Sanofi Pasteur

Japan BCG Lab

China National Biotec

Intervax

Serum Institute of India

GreenSignal

Statens Serum Institute

Shanyao Group

Shanghai Institute of Biological Products

List of Tables

Table 1. Global BCG Vaccine for Prevent Covid-19 Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global BCG Vaccine for Prevent Covid-19 Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global BCG Vaccine for Prevent Covid-19 Market Competitive Situation by Manufacturers in 2023

Table 4. Global BCG Vaccine for Prevent Covid-19 Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Manufacturers (2019-2024)

Table 6. Global BCG Vaccine for Prevent Covid-19 Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global BCG Vaccine for Prevent Covid-19 Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market BCG Vaccine for Prevent Covid-19 Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of BCG Vaccine for Prevent Covid-19, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of BCG Vaccine for Prevent Covid-19, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of BCG Vaccine for Prevent Covid-19, Product Type & Application

Table 12. Global Key Manufacturers of BCG Vaccine for Prevent Covid-19, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global BCG Vaccine for Prevent Covid-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Prevent Covid-19 as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global BCG Vaccine for Prevent Covid-19 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global BCG Vaccine for Prevent Covid-19 Sales by Region (2019-2024) & (K Doses)

Table 18. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Region (2019-2024)

Table 19. Global BCG Vaccine for Prevent Covid-19 Sales by Region (2025-2030) & (K Doses)

Table 20. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Region (2025-2030)

Table 21. Global BCG Vaccine for Prevent Covid-19 Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Region (2019-2024)

Table 23. Global BCG Vaccine for Prevent Covid-19 Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Region (2025-2030)

Table 25. North America BCG Vaccine for Prevent Covid-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)

Table 27. North America BCG Vaccine for Prevent Covid-19 Sales by Country (2025-2030) & (K Doses)

Table 28. North America BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America BCG Vaccine for Prevent Covid-19 Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe BCG Vaccine for Prevent Covid-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)

Table 32. Europe BCG Vaccine for Prevent Covid-19 Sales by Country (2025-2030) & (K Doses)

Table 33. Europe BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe BCG Vaccine for Prevent Covid-19 Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific BCG Vaccine for Prevent Covid-19 Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific BCG Vaccine for Prevent Covid-19 Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific BCG Vaccine for Prevent Covid-19 Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific BCG Vaccine for Prevent Covid-19 Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific BCG Vaccine for Prevent Covid-19 Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America BCG Vaccine for Prevent Covid-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America BCG Vaccine for Prevent Covid-19 Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America BCG Vaccine for Prevent Covid-19 Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global BCG Vaccine for Prevent Covid-19 Sales (K Doses) by Type (2019-2024)

Table 51. Global BCG Vaccine for Prevent Covid-19 Sales (K Doses) by Type (2025-2030)

Table 52. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2019-2024)

Table 53. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Type (2025-2030)

Table 54. Global BCG Vaccine for Prevent Covid-19 Revenue (US$ Million) by Type (2019-2024)

Table 55. Global BCG Vaccine for Prevent Covid-19 Revenue (US$ Million) by Type (2025-2030)

Table 56. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Type (2019-2024)

Table 57. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Type (2025-2030)

Table 58. Global BCG Vaccine for Prevent Covid-19 Price (USD/Dose) by Type (2019-2024)

Table 59. Global BCG Vaccine for Prevent Covid-19 Price (USD/Dose) by Type (2025-2030)

Table 60. Global BCG Vaccine for Prevent Covid-19 Sales (K Doses) by Application (2019-2024)

Table 61. Global BCG Vaccine for Prevent Covid-19 Sales (K Doses) by Application (2025-2030)

Table 62. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2019-2024)

Table 63. Global BCG Vaccine for Prevent Covid-19 Sales Market Share by Application (2025-2030)

Table 64. Global BCG Vaccine for Prevent Covid-19 Revenue (US$ Million) by Application (2019-2024)

Table 65. Global BCG Vaccine for Prevent Covid-19 Revenue (US$ Million) by Application (2025-2030)

Table 66. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Application (2019-2024)

Table 67. Global BCG Vaccine for Prevent Covid-19 Revenue Market Share by Application (2025-2030)

Table 68. Global BCG Vaccine for Prevent Covid-19 Price (USD/Dose) by Application (2019-2024)

Table 69. Global BCG Vaccine for Prevent Covid-19 Price (USD/Dose) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Merck BCG Vaccine for Prevent Covid-19 Product

Table 74. Merck Recent Developments/Updates

Table 75. Sanofi Pasteur Corporation Information

Table 76. Sanofi Pasteur Description and Business Overview

Table 77. Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. Sanofi Pasteur BCG Vaccine for Prevent Covid-19 Product

Table 79. Sanofi Pasteur Recent Developments/Updates

Table 80. Japan BCG Lab Corporation Information

Table 81. Japan BCG Lab Description and Business Overview

Table 82. Japan BCG Lab BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Japan BCG Lab BCG Vaccine for Prevent Covid-19 Product

Table 84. Japan BCG Lab Recent Developments/Updates

Table 85. China National Biotec Corporation Information

Table 86. China National Biotec Description and Business Overview

Table 87. China National Biotec BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. China National Biotec BCG Vaccine for Prevent Covid-19 Product

Table 89. China National Biotec Recent Developments/Updates

Table 90. InterVax Corporation Information

Table 91. InterVax Description and Business Overview

Table 92. InterVax BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. InterVax BCG Vaccine for Prevent Covid-19 Product

Table 94. InterVax Recent Developments/Updates

Table 95. Serum Institute of India Corporation Information

Table 96. Serum Institute of India Description and Business Overview

Table 97. Serum Institute of India BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Serum Institute of India BCG Vaccine for Prevent Covid-19 Product

Table 99. Serum Institute of India Recent Developments/Updates

Table 100. GreenSignal Corporation Information

Table 101. GreenSignal Description and Business Overview

Table 102. GreenSignal BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. GreenSignal BCG Vaccine for Prevent Covid-19 Product

Table 104. GreenSignal Recent Developments/Updates

Table 105. Statens Serum Institute Corporation Information

Table 106. Statens Serum Institute Description and Business Overview

Table 107. Statens Serum Institute BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 108. Statens Serum Institute BCG Vaccine for Prevent Covid-19 Product

Table 109. Statens Serum Institute Recent Developments/Updates

Table 110. Shanyao Group Corporation Information

Table 111. Shanyao Group Description and Business Overview

Table 112. Shanyao Group BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 113. Shanyao Group BCG Vaccine for Prevent Covid-19 Product

Table 114. Shanyao Group Recent Developments/Updates

Table 115. Shanghai Institute of Biological Products Corporation Information

Table 116. Shanghai Institute of Biological Products Description and Business Overview

Table 117. Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 118. Shanghai Institute of Biological Products BCG Vaccine for Prevent Covid-19 Product

Table 119. Shanghai Institute of Biological Products Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. BCG Vaccine for Prevent Covid-19 Distributors List

Table 123. BCG Vaccine for Prevent Covid-19 Customers List

Table 124. BCG Vaccine for Prevent Covid-19 Market Trends

Table 125. BCG Vaccine for Prevent Covid-19 Market Drivers

Table 126. BCG Vaccine for Prevent Covid-19 Market Challenges

Table 127. BCG Vaccine for Prevent Covid-19 Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of BCG Vaccine for Prevent Covid-19

Figure 2. Global BCG Vaccine for Prevent Covid-19 Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global BCG Vaccine for Prevent Covid-19 Market Share by Type in 2023 & 2030

Figure 4. 0.5ml Package Product Picture

Figure 5. 1ml Package Product Picture

Figure 6. 2ml Package Product Picture

Figure 7. Other Product Picture

Figure 8. Global BCG Vaccine for Prevent Covid-19 Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global BCG Vaccine for Prevent Covid-19 Market Share by Application in 2023 & 2030

Figure 10. 0-5 Years Old

Figure 11. 5-18 Years Old

Figure 12. 18-45 Years Old

Figure 13. 45-65 Years Old

Figure 14. ≥65 Years Old

Figure 15. Global BCG Vaccine for Prevent Covid-19 Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global BCG Vaccine for Prevent Covid-19 Market Size (2019-2030) & (US$ Million)

Figure 17. Global BCG Vaccine for Prevent Covid-19 Sales (2019-2030) & (K Doses)

Figure 18. Global BCG Vaccine for Prevent Covid-19 Average Price (USD/Dose) & (2019-2030)

Figure 19. BCG Vaccine for Prevent Covid-19 Report Years Considered

Figure 20. BCG Vaccine for Prevent Covid-19 Sales Share by Manufacturers in 2023

Figure 21. Global BCG Vaccine for Prevent Covid-19 Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest BCG Vaccine for Prevent Covid-19 Players: Market Share by Revenue in 2023

Figure 23. BCG Vaccine for Prevent Covid-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global BCG Vaccine for Prevent Covid-19 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2030)

Figure 26. North America BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2030)

Figure 27. U.S. BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2030)

Figure 30. Europe BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2030)

Figure 31. Germany BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific BCG Vaccine for Prevent Covid-19 Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific BCG Vaccine for Prevent Covid-19 Revenue Market Share by Region (2019-2030)

Figure 38. China BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Taiwan BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Philippines BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2030)

Figure 49. Latin America BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2030)

Figure 50. Mexico BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa BCG Vaccine for Prevent Covid-19 Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa BCG Vaccine for Prevent Covid-19 Revenue Market Share by Country (2019-2030)

Figure 55. Turkey BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. UAE BCG Vaccine for Prevent Covid-19 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of BCG Vaccine for Prevent Covid-19 by Type (2019-2030)

Figure 59. Global Revenue Market Share of BCG Vaccine for Prevent Covid-19 by Type (2019-2030)

Figure 60. Global BCG Vaccine for Prevent Covid-19 Price (USD/Dose) by Type (2019-2030)

Figure 61. Global Sales Market Share of BCG Vaccine for Prevent Covid-19 by Application (2019-2030)

Figure 62. Global Revenue Market Share of BCG Vaccine for Prevent Covid-19 by Application (2019-2030)

Figure 63. Global BCG Vaccine for Prevent Covid-19 Price (USD/Dose) by Application (2019-2030)

Figure 64. BCG Vaccine for Prevent Covid-19 Value Chain

Figure 65. BCG Vaccine for Prevent Covid-19 Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions